Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Simple notes about subjective experience, objective measurements, and any concerns enable informed decisions about continuing, adjusting, or discontinuing individual components
Preclinical Evidence Comparison Multiple independent preclinical and in vitro studies have confirmed the significant advantages of SAG in terms of bioavailability
FOXO4-DRI Dosing Context & Schedule There is no validated human dose for FOXO4-DRI
Carcinogenesis 20 , 553559 (1999)
Made in the USA Produced in a GMP-certified facility with batch-to-batch control
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
